ProSomnus Inc. (OSAP)
OTCMKTS: OSAP · Delayed Price · USD
0.101
0.00 (0.00%)
May 2, 2024, 12:00 AM EDT - Market open
ProSomnus Revenue
In the year 2023, ProSomnus had annual revenue of $27.65M with 42.59% growth. Revenue in the quarter ending December 31, 2023 was $7.84M with 35.33% year-over-year growth.
Revenue (ttm)
$27.65M
Revenue Growth
+42.59%
P/S Ratio
0.30
Revenue / Employee
$203,324
Employees
136
Market Cap
8.18M
Revenue Chart
* The company reports in USD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27.65M | 8.26M | 42.59% |
Dec 31, 2022 | 19.39M | 5.32M | 37.79% |
Dec 31, 2021 | 14.07M | 5.79M | 69.86% |
Dec 31, 2020 | 8.29M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOSAP News
- 5 weeks ago - ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results - GlobeNewsWire
- 7 weeks ago - ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call - GlobeNewsWire
- 2 months ago - Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI) - Benzinga
- 2 months ago - ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea - GlobeNewsWire
- 3 months ago - ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices - GlobeNewsWire
- 6 months ago - ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results - GlobeNewsWire
- 6 months ago - ProSomnus Announces Third Quarter 2023 Investor Call and Business Update - GlobeNewsWire
- 7 months ago - ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference - GlobeNewsWire